Revaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patients
Christian Gytz Ammitzbøll(Aarhus University), Anne Troldborg(Aarhus University), Jens Magnus Bernth Jensen(Aarhus University Hospital), Susan Mikkelsen(Aarhus University Hospital), Martin Tolstrup(Aarhus University), Signe Risbøl Vils(Aarhus University), Ole S. Søgaard(Aarhus University Hospital), Rikke Olesen(Aarhus University Hospital), Laura Pérez‐Alós(Copenhagen University Hospital), Marie‐Louise From Hermansen(Aarhus University Hospital), Mads Lamm Larsen(Aarhus University), Anders Dahl Johannsen(Aarhus University Hospital), Christian Erikstrup(Aarhus University Hospital), Rafael Bayarri‐Olmos(Copenhagen University Hospital), Peter Garred(University of Copenhagen), Marianne Kragh Thomsen(Aarhus University), J.B. Andersen(Aarhus University Hospital), Lena Nielsen(Aarhus University), Fruzsina Szabados, Clara Elbæk Mistegaard(Aarhus University), Ellen‐Margrethe Hauge(Aarhus University)
Cited by 3
Related Papers
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
|PLoS Pathogens|2015|522
Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles
|Nature Genetics|2022|396
Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers
|Journal of Bone and Mineral Research|2001|384
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
|Nature Medicine|2021|367